Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Real world test characteristics of mass spectrometry monoclonal protein monitoring in multiple myeloma

Kevin Shim, Mariano Arribas, Fabio Samir Vargas Cely, Udit Yadav, J Wiedmeier-Nutor, Nathan Punwani, Gabriela Alatorre, Sharene Best, Katalin Kelemen, Saurabh Chhabra, P. Leif Bergsagel, David Murray, Rafael Fonseca

Blood (2025) 146 (Supplement 1): 2201.

https://doi.org/10.1182/blood-2025-2201

Published: 2025

Journal Articles

Tumor intrinsic mechanisms leading to cevostamab resistance in multiple myeloma

Blood (2025) 146 (Supplement 1): 2178.

https://doi.org/10.1182/blood-2025-2178

Published: 2025

Journal Articles

Prognostic value of immunoparesis, lymphopenia, high serum ferritin, and suppression of the non-involved serum free light chains (niFLC) in relapsed and refractory multiple myeloma patients (RRMM) receiving bispecific antibodies

Blood (2025) 146 (Supplement 1): 5772.

https://doi.org/10.1182/blood-2025-5772

Published: 2025

Journal Articles

Comparative analysis of next generation flow (NGF) and next generation sequencing based clonoseq for MRD detection in multiple myeloma using paired bone marrow samples

J Wiedmeier-Nutor, Mariano Arribas, Karl Franke, Juana Figueroa Aguirre, Katalin Kelemen, Udit Yadav, P. Leif Bergsagel, Saurabh Chhabra, Rafael Fonseca

Blood (2025) 146 (Supplement 1): 4020.

https://doi.org/10.1182/blood-2025-4020

Published: 2025

Journal Articles

Pre-Infusion Ferritin: A Predictive Biomarker for CAR T-Cell Therapy Response in Multiple Myeloma

Eider Moreno, Mariano Arribas, David A. Martinez, Juana Figueroa Aguirre, Rohan S Patel, Udit Yadav, Erin J Wiedmeier-Nutor, Leif Bergsagel, Rafael Fonseca, Saurabh Chhabra, Januario E. Castro

Blood (2024) 144 (Supplement 1): 7096.

https://doi.org/10.1182/blood-2024-211376

Published: 2024

Journal Articles

A Proteogenomic Approach to Identify Potential Drivers of Hyperdiploid Multiple Myeloma

J Erin Wiedmeier-Nutor, Surendra Dasari, Richard Kumaran Kandasamy, Kiran Manalaparthi, Laura Ann Bruins, Gregory Ahmann, Mariano Arribas, P. Leif Bergsagel, Akhilesh Pandey, Esteban Braggio, Rafael Fonseca

Blood (2024) 144 (Supplement 1): 3269.

https://doi.org/10.1182/blood-2024-206239

Published: 2024

Journal Articles

Beyond the Primary: Unveiling the Prognostic Value of Secondary Cytogenetic Abnormalities in Multiple Myeloma

Rodrigo Fonseca, Mariano Arribas, Gregory Ahmann, Janna C Castro, Erin E Wiedmeier-Nutor, Linda Banovic Baughn, P. Leif Bergsagel, Rafael Fonseca

Blood (2023) 142 (Supplement 1): 2000.

https://doi.org/10.1182/blood-2023-190701

Published: 2023

Journal Articles

Electrocardiogram As a Marker of Cardiac Response in Light Chain Amyloidosis

Rodrigo Fonseca, Yael Kusne, Mariano Arribas, Molly Klanderman, Julia E. Wiedmeier, Eli Muchtar, P. Leif Bergsagel, Craig B. Reeder, Jeremy T. Larsen, Rafael Fonseca, Julie L Rosenthal

Blood (2022) 140 (Supplement 1): 12566–12567.

https://doi.org/10.1182/blood-2022-168083

Published: 2022

Journal Articles

A Single Next Generation Sequencing Assay for Detection of Driver Mutations, Translocations and Copy Number Alterations in Patients with Multiple Myeloma

Cecilia Bonolo De Campos, James B Smadbeck, Mariano Arribas, Neeraj Sharma, Gregory J Ahmann, Shaji K Kumar, A. Keith Stewart, Rafael Fonseca, P. Leif Bergsagel, Yan Asmann, Linda B. Baughn, Esteban Braggio

Blood (2022) 140 (Supplement 1): 7180–7181.

https://doi.org/10.1182/blood-2022-170749

Published: 2022

Journal Articles

Cyclophosphamide-Bortezomib-Dexamethasone (CyBorD) +/- Daratumumab Treatment Results in Sustained Hematologic Response in Patients with AL Amyloidosis: A Retrospective Analysis of Patients at Mayo Clinic

Yael Kusne, Rodrigo Fonseca, Mariano Arribas, Molly Klanderman, Julia E. Wiedmeier, Craig B. Reeder, Jeremy T. Larsen, P. Leif Bergsagel, Julie L Rosenthal, Rafael Fonseca

Blood (2022) 140 (Supplement 1): 7224–7225.

https://doi.org/10.1182/blood-2022-166668

Published: 2022

Journal Articles

Newly Diagnosed, Untreated, Multiple Myeloma (MM) Patient Samples Already Harbor Cereblon (CRBN) Exon 10 Deletions Associated with Drug Resistance

Yuan Xiao Zhu, Gregory J Ahmann, Laura Ann Bruins, Mariano Arribas, Xianfeng Chen, Marta Chesi, P. Leif Bergsagel, Rafael Fonseca, Lisa M. Rimsza

Blood (2022) 140 (Supplement 1): 4187–4188.

https://doi.org/10.1182/blood-2022-157316

Published: 2022

Journal Articles

Identifying Mechanisms Associated with Venetoclax Resistance in Multiple Myeloma (MM)

Yuan Xiao Zhu, Laura Ann Bruins, Joseph Ahmann, Cecilia Bonolo De Campos, Esteban Braggio, Xianfeng Chen, Mariano Arribas, Susie Darvish, Gregory J Ahmann, Rafael Fonseca

Blood (2021) 138 (Supplement 1): 2668.

https://doi.org/10.1182/blood-2021-153747

Published: 2021

Journal Articles

Measles, Mumps & Rubella Titers Post Autologous Stem Cell Transplant in Multiple Myeloma Patients Induced with Modern Therapy

Mariano Arribas, Gregory J Ahmann, BS, Skye Buckner-Petty, MPH, Esteban Braggio, PhD, Elitza S Theel, PhD, Rafael Fonseca, MD

Blood (2020) 136 (Supplement 1): 43.

https://doi.org/10.1182/blood-2020-142616

Published: 2020

Journal Articles

Improving the Definition of Response Assessment: Prognostic Value of Minimal Residual Disease Combined with PET/CT at Day 100 Post Autologous Stem Cell Transplantation in Multiple Myeloma

Miguel Gonzalez-Velez, MD, Mariano Arribas, Heidi E. Kosiorek, MS, Richard Butterfield, III, Carlo Guerrero, MD, Luke Mountjoy, DO, Jeremy Larsen, Craig B. Reeder, MD, P. Leif Bergsagel, MD, A. Keith Stewart, MB, ChB, Rafael Fonseca, MD

Blood (2020) 136 (Supplement 1): 33–34.

https://doi.org/10.1182/blood-2020-142845

Published: 2020

Update search

NARROW

Publications

Format

Article Type

Date

Availability

Real world test characteristics of mass spectrometry monoclonal protein monitoring in multiple myeloma

Tumor intrinsic mechanisms leading to cevostamab resistance in multiple myeloma

Prognostic value of immunoparesis, lymphopenia, high serum ferritin, and suppression of the non-involved serum free light chains (niFLC) in relapsed and refractory multiple myeloma patients (RRMM) receiving bispecific antibodies

Comparative analysis of next generation flow (NGF) and next generation sequencing based clonoseq for MRD detection in multiple myeloma using paired bone marrow samples

Pre-Infusion Ferritin: A Predictive Biomarker for CAR T-Cell Therapy Response in Multiple Myeloma

A Proteogenomic Approach to Identify Potential Drivers of Hyperdiploid Multiple Myeloma

Beyond the Primary: Unveiling the Prognostic Value of Secondary Cytogenetic Abnormalities in Multiple Myeloma

Electrocardiogram As a Marker of Cardiac Response in Light Chain Amyloidosis

A Single Next Generation Sequencing Assay for Detection of Driver Mutations, Translocations and Copy Number Alterations in Patients with Multiple Myeloma

Cyclophosphamide-Bortezomib-Dexamethasone (CyBorD) +/- Daratumumab Treatment Results in Sustained Hematologic Response in Patients with AL Amyloidosis: A Retrospective Analysis of Patients at Mayo Clinic

Newly Diagnosed, Untreated, Multiple Myeloma (MM) Patient Samples Already Harbor Cereblon (CRBN) Exon 10 Deletions Associated with Drug Resistance

Identifying Mechanisms Associated with Venetoclax Resistance in Multiple Myeloma (MM)

Measles, Mumps & Rubella Titers Post Autologous Stem Cell Transplant in Multiple Myeloma Patients Induced with Modern Therapy

Improving the Definition of Response Assessment: Prognostic Value of Minimal Residual Disease Combined with PET/CT at Day 100 Post Autologous Stem Cell Transplantation in Multiple Myeloma

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only